What patents protect the Yenos nanopore miRNA detection platform?

Dr. Anastassia Kanavarioti and Yenos Analytical hold three US granted patents protecting the MinION/Yenos nanopore miRNA quantification platform. Additionally, international patents have been granted or are pending in eight countries. The patents cover the osmium metalorganic probe chemistry for nucleic acid tagging, the method of using nanopore current blockage events to quantify specific miRNA molecules, and the HL normalization method for clinical miRNA quantification from urine. These patents create a proprietary moat around the zero-amplification, single-molecule miRNA quantification approach that is the scientific core of OncuraKit.